Skip to main content

D. E. Shaw & Co., Inc.

Position in GH — Guardant Health, Inc.

CIK 1009207 New York, NY

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$188,386,369
+$148,900,504 QoQ
Shares Held
1,255,658
+193.7% QoQ
Ownership
0.936%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#34
of 594 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Jun 30, 2026
CallValue
$495,099
CallShares
3,300
PutValue
$2,385,477
PutShares
15,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $2,287,511,101 across 27 Diagnostics & Research names. GH ranks #6 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GH
Guardant Health, Inc.
This page
1,255,658 $188,386,369

All Filings in GH

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $495,099 3,300
2026-06-30 $188,386,369 1,255,658
2026-06-30 $2,385,477 15,900
2026-03-31 $1,468,683 15,900
2026-03-31 $39,485,865 427,475
2025-12-31 $63,639,041 623,057
2025-09-30 $724,768 11,600
2025-09-30 $2,083,520 33,347
2024-12-31 $449,085 14,700
2024-09-30 $387,686 16,900
2024-06-30 $488,072 16,900
2024-03-31 $348,647 16,900
2024-03-31 $2,268,123 109,943
2023-12-31 $3,679,584 136,029
2023-09-30 $6,701,366 226,092
2023-06-30 $422,440 11,800
2023-03-31 $11,501,328 490,671
2022-06-30 $379,196 9,400
2021-09-30 $8,951,215 71,604
2021-06-30 $28,406,226 228,732
2021-03-31 $41,017,360 268,702
2020-12-31 $5,690,438 44,153
2020-09-30 $1,218,960 10,905
2020-03-31 $736,855 10,587